Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Taya

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Oncogene|March 29, 2000
HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestrationY Ariumi, A Kaida, J Y Lin, et al.
Molecular Cell|August 21, 2001
p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosisS Okamura, H Arakawa, T Tanaka, et al.
European Journal of Biochemistry|April 15, 1996
Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-HH Higashi, I Suzuki-Takahashi, S Saitoh, et al.
Oncogene|March 21, 2000
Ionizing radiation activates the ATM kinase throughout the cell cycleT K Pandita, H B Lieberman, D S Lim, et al.
Oncogene|November 11, 1999
The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 associationY Nagata, T Anan, T Yoshida, et al.
Electromyography and Clinical Neurophysiology|February 20, 2002
Influence of hyperbaric environment on physiological tremorK Sakamoto, N Itakura, M Takanokura, et al.
Oncogene|January 19, 1995
Phosphorylation of E2F-1 by cyclin A-cdk2M Kitagawa, H Higashi, I Suzuki-Takahashi, et al.
Journal of Dental Research|December 25, 2015
MALT1 Inhibition of Oral Carcinoma Cell Invasion and ERK/MAPK ActivationT Chiba, Y Soeno, Y Shirako, et al.
The EMBO Journal|December 1, 1984
A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancerY Taya, K Hosogai, S Hirohashi, et al.
Biochemical and Biophysical Research Communications|July 30, 1999
The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53D Keller, X Zeng, X Li, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Oncogene|March 29, 2000
HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestrationY Ariumi, A Kaida, J Y Lin, et al.
Molecular Cell|August 21, 2001
p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosisS Okamura, H Arakawa, T Tanaka, et al.
European Journal of Biochemistry|April 15, 1996
Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-HH Higashi, I Suzuki-Takahashi, S Saitoh, et al.
Oncogene|March 21, 2000
Ionizing radiation activates the ATM kinase throughout the cell cycleT K Pandita, H B Lieberman, D S Lim, et al.
Oncogene|November 11, 1999
The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 associationY Nagata, T Anan, T Yoshida, et al.
Electromyography and Clinical Neurophysiology|February 20, 2002
Influence of hyperbaric environment on physiological tremorK Sakamoto, N Itakura, M Takanokura, et al.
Oncogene|January 19, 1995
Phosphorylation of E2F-1 by cyclin A-cdk2M Kitagawa, H Higashi, I Suzuki-Takahashi, et al.
Journal of Dental Research|December 25, 2015
MALT1 Inhibition of Oral Carcinoma Cell Invasion and ERK/MAPK ActivationT Chiba, Y Soeno, Y Shirako, et al.
The EMBO Journal|December 1, 1984
A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancerY Taya, K Hosogai, S Hirohashi, et al.
Biochemical and Biophysical Research Communications|July 30, 1999
The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53D Keller, X Zeng, X Li, et al.
Pageof 12